These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 10912572)
1. Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours. Harrington KJ; Rowlinson-Busza G; Uster PS; Stewart JS Cancer Chemother Pharmacol; 2000; 46(1):10-8. PubMed ID: 10912572 [TBL] [Abstract][Full Text] [Related]
2. Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model. Harrington KJ; Rowlinson-Busza G; Syrigos KN; Vile RG; Uster PS; Peters AM; Stewart JS Clin Cancer Res; 2000 Dec; 6(12):4939-49. PubMed ID: 11156255 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395 [TBL] [Abstract][Full Text] [Related]
4. The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent. Sasaki Y; Kjellén E; Ekblad L; Wahlberg P; Mineta H; Wennerberg J Oral Oncol; 2012 Jan; 48(1):61-6. PubMed ID: 21963040 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465 [TBL] [Abstract][Full Text] [Related]
6. Polymer chemotherapy for head and neck cancer. Shikani AH; Domb AJ Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503 [TBL] [Abstract][Full Text] [Related]
7. Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long-circulating pegylated stealth liposomes. Vaage J; Donovan D; Wipff E; Abra R; Colbern G; Uster P; Working P Int J Cancer; 1999 Jan; 80(1):134-7. PubMed ID: 9935243 [TBL] [Abstract][Full Text] [Related]
8. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502 [TBL] [Abstract][Full Text] [Related]
9. Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes. Williams SS; Alosco TR; Mayhew E; Lasic DD; Martin FJ; Bankert RB Cancer Res; 1993 Sep; 53(17):3964-7. PubMed ID: 8358724 [TBL] [Abstract][Full Text] [Related]
10. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130 [TBL] [Abstract][Full Text] [Related]
11. Vascular targeting of doxorubicin using cationic liposomes. Wu J; Lee A; Lu Y; Lee RJ Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230 [TBL] [Abstract][Full Text] [Related]
12. Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer. Los G; Benbatoul K; Gately DP; Barton R; Christen R; Robbins KT; Vicario D; Kirmani S; Orloff LA; Weisman R; Howell SB Clin Cancer Res; 1999 Jul; 5(7):1610-8. PubMed ID: 10430059 [TBL] [Abstract][Full Text] [Related]
13. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model. Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659 [TBL] [Abstract][Full Text] [Related]
14. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells. Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522 [TBL] [Abstract][Full Text] [Related]
15. Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment. Peng PC; Hong RL; Tsai YJ; Li PT; Tsai T; Chen CT Lasers Surg Med; 2015 Jan; 47(1):77-87. PubMed ID: 25559348 [TBL] [Abstract][Full Text] [Related]
16. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. Jeremic B; Milicic B; Dagovic A; Vaskovic Z; Tadic L J Clin Oncol; 2004 Sep; 22(17):3540-8. PubMed ID: 15337803 [TBL] [Abstract][Full Text] [Related]
17. Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse model. Tuscano JM; Martin SM; Ma Y; Zamboni W; O'Donnell RT Clin Cancer Res; 2010 May; 16(10):2760-8. PubMed ID: 20460479 [TBL] [Abstract][Full Text] [Related]
18. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells. Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729 [TBL] [Abstract][Full Text] [Related]
19. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Gabizon A; Catane R; Uziely B; Kaufman B; Safra T; Cohen R; Martin F; Huang A; Barenholz Y Cancer Res; 1994 Feb; 54(4):987-92. PubMed ID: 8313389 [TBL] [Abstract][Full Text] [Related]
20. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]